Vanguard Group
KMTS

Vanguard Group’s Kestra Medical Technologies KMTS Stock Holding History

Vanguard Group’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$33.8M Buy
1,274,330
+522,181
+69% +$13.4M ﹤0.01% 2378
2025
Q3 		$17.9M Sell
752,149
-10,339
-1% -$185K ﹤0.01% 2678
2025
Q2 		$12.6M Buy
762,488
+722,488
+1,806% +$15.8M ﹤0.01% 2782
2025
Q1 		$997K Buy
+40,000
New +$919K ﹤0.01% 3710

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group's KMTS Position: Q4 2025 in Review

Vanguard Group increased its Kestra Medical Technologies (KMTS) stake by 69% in Q4 2025, buying an estimated $13.4M and bringing the position to 1,274,330 shares worth $33.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2378.

Vanguard Group first reported a position in KMTS in Q1 2025 and has held it in 4 quarters since. 107 funds tracked by Wall St. Rank hold KMTS as of Q4 2025.

  • Vanguard Group held 1,274,330 shares of Kestra Medical Technologies worth $33.8M as of Q4 2025.
  • Vanguard Group bought 522,181 Kestra Medical Technologies shares in Q4 2025, an estimated $13.4M.
  • Kestra Medical Technologies made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2378 holding.
  • Vanguard Group first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 4 quarters since.
  • 107 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.